The first patient has been dosed in the Phase 1 Trial of SEL-403. This trial uses a drug that combines nanoparticles containing rapamycin (SVP-R)—a drug that controls cell growth—with the protein-based drug LMB-100 in order to treat tumors caused by pleural or peritoneal mesothelioma. Earlier studies have shown that recombinant immunotoxins (molecules that kill cancer […]
The post Phase 1 Testing Begins on New Clinical Drug Trial for Mesothelioma appeared first on Mesothelioma Help Now.
from Mesothelioma Help Now https://ift.tt/2jni87f
via IFTTT
Phase 1 Testing Begins on New Clinical Drug Trial for Mesothelioma
![Phase 1 Testing Begins on New Clinical Drug Trial for Mesothelioma]()
Reviewed by Unknown
on
May 02, 2018
Rating:
No comments: